Lead Ventures Inc Stock Canadian Securities Exchange
Stocks
LEAD
CA5542341048
Pharmaceuticals
OTC Markets Traded|
Delayed
Canadian Securities Exchange
|
5-day change | 1st Jan Change | ||
| - CAD | -.--% |
|
-.--% | -37.50% |
| 09-17 | Curaleaf Holdings, Inc. - Shareholder/Analyst Call | |
| 09-16 | Curaleaf to Open New Dispensaries in Philadelphia and Florida | MT |
| Market Cap | 2.77B 2.42B 2.28B 2.07B 3.89B 265B 3.89B 27.25B 10.5B 135B 10.41B 10.18B 436B | P/E 2026 * |
209x | P/E 2027 * | -35.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.36B 2.93B 2.76B 2.51B 4.71B 322B 4.72B 33.06B 12.74B 164B 12.63B 12.35B 529B | EV / Sales 2026 * |
2.46x | EV / Sales 2027 * | 2.18x |
| Free-Float |
65.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lead Ventures Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Boris Jordan
CEO | Chief Executive Officer | 60 | 16/08/2024 |
Rahul Pinto
PSD | President | - | 16/06/2025 |
Edward Kremer
DFI | Director of Finance/CFO | 54 | 08/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Boris Jordan
CHM | Chairman | 60 | 01/01/2015 |
Joseph Lusardi
BRD | Director/Board Member | 52 | 01/03/2016 |
Karl Johansson
BRD | Director/Board Member | 76 | 01/08/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.77B | |
| +0.82% | +5.48% | +41.55% | -9.36% | 2.77B | |
| +2.50% | -7.61% | -17.17% | +148.48% | 558M | |
| 0.00% | -5.66% | -13.79% | -37.50% | 54.53M | |
| Average | +0.90% | +1.50% | +3.53% | +33.88% | 1.13B | |
| Weighted average by Cap. | +0.72% | +7.78% | +30.98% | +16.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.37B 1.19B 1.12B 1.02B 1.92B 131B 1.92B 13.44B 5.18B 66.7B 5.13B 5.02B 215B | 1.49B 1.29B 1.22B 1.11B 2.08B 142B 2.09B 14.61B 5.63B 72.48B 5.58B 5.46B 234B |
| Net income | 2.92M 2.55M 2.4M 2.18M 4.09M 280M 4.1M 28.71M 11.07M 142M 10.97M 10.72M 460M | -96.79M -84.39M -79.48M -72.38M -136M -9.27B -136M -952M -367M -4.72B -364M -356M -15.24B |
| Net Debt | 590M 514M 485M 441M 827M 56.52B 828M 5.8B 2.24B 28.79B 2.22B 2.17B 92.91B | 472M 412M 388M 353M 663M 45.27B 663M 4.65B 1.79B 23.06B 1.77B 1.74B 74.41B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CURA Stock
- LEAD Stock
Select your edition
All financial news and data tailored to specific country editions
